RAISED

levels of a protein have been found in the blood of patients with rheumatoid arthritis, a breakthrough that could lead to new treatments. The protein, CCL17, is involved in inflammation. Now researchers from the University of Melbourne want to investigate whether CCL17-blocking drugs could be used to halt the condition’s progress.